SF1670 is primarily recognized for its role as a potent inhibitor of PTEN (Phosphatase and Tensin Homolog), a protein that regulates cell growth and survival. By inhibiting PTEN, SF1670 enhances the activity of the PI3K/AKT signaling pathway, which is crucial for various cellular processes including metabolism, proliferation, and apoptosis. This makes SF1670 a valuable tool in biomedical research, particularly in studies focused on understanding cancer biology, as the PI3K/AKT pathway is often dysregulated in many types of cancer. Researchers utilize SF1670 to explore potential therapeutic strategies that target this pathway, aiming to develop treatments that can inhibit tumor growth and improve cancer outcomes. Additionally, SF1670 is used in studies investigating cellular responses to stress and in the development of regenerative medicine approaches, where modulation of cell survival pathways is essential.